Abstract
Early outcomes from a phase II randomized trial testing stereotactic body radiation therapy in patients undergoing I line treatment with abiraterone acetate for oligometastatic castration resistant prostate cancer (ARTO trial-NCT03449719)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have